AVITA Medical (RCEL) Competitors $10.30 +0.20 (+1.98%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends RCEL vs. PLSE, MDXG, AVNS, LQDA, EYE, EMBC, CATX, KIDS, IRMD, and AXGNShould you be buying AVITA Medical stock or one of its competitors? The main competitors of AVITA Medical include Pulse Biosciences (PLSE), MiMedx Group (MDXG), Avanos Medical (AVNS), Liquidia (LQDA), National Vision (EYE), Embecta (EMBC), Perspective Therapeutics (CATX), OrthoPediatrics (KIDS), Iradimed (IRMD), and AxoGen (AXGN). These companies are all part of the "medical equipment" industry. AVITA Medical vs. Pulse Biosciences MiMedx Group Avanos Medical Liquidia National Vision Embecta Perspective Therapeutics OrthoPediatrics Iradimed AxoGen Pulse Biosciences (NASDAQ:PLSE) and AVITA Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, community ranking, dividends and earnings. Do analysts rate PLSE or RCEL? AVITA Medical has a consensus price target of $15.00, indicating a potential upside of 45.63%. Given AVITA Medical's higher possible upside, analysts plainly believe AVITA Medical is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AAVITA Medical 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Do institutionals & insiders hold more shares of PLSE or RCEL? 77.0% of Pulse Biosciences shares are held by institutional investors. Comparatively, 27.7% of AVITA Medical shares are held by institutional investors. 71.5% of Pulse Biosciences shares are held by company insiders. Comparatively, 1.8% of AVITA Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is PLSE or RCEL more profitable? Pulse Biosciences has a net margin of 0.00% compared to AVITA Medical's net margin of -92.04%. Pulse Biosciences' return on equity of -96.89% beat AVITA Medical's return on equity.Company Net Margins Return on Equity Return on Assets Pulse BiosciencesN/A -96.89% -74.83% AVITA Medical -92.04%-118.27%-52.75% Which has more volatility & risk, PLSE or RCEL? Pulse Biosciences has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Comparatively, AVITA Medical has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500. Which has stronger valuation & earnings, PLSE or RCEL? AVITA Medical has higher revenue and earnings than Pulse Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulse Biosciences$700K1,279.62-$42.21MN/AN/AAVITA Medical$54.14M4.94-$35.38M-$1.95-5.28 Does the media prefer PLSE or RCEL? In the previous week, Pulse Biosciences had 11 more articles in the media than AVITA Medical. MarketBeat recorded 12 mentions for Pulse Biosciences and 1 mentions for AVITA Medical. Pulse Biosciences' average media sentiment score of 0.48 beat AVITA Medical's score of 0.00 indicating that Pulse Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulse Biosciences 3 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AVITA Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor PLSE or RCEL? Pulse Biosciences received 173 more outperform votes than AVITA Medical when rated by MarketBeat users. However, 68.52% of users gave AVITA Medical an outperform vote while only 64.49% of users gave Pulse Biosciences an outperform vote. CompanyUnderperformOutperformPulse BiosciencesOutperform Votes24764.49% Underperform Votes13635.51% AVITA MedicalOutperform Votes7468.52% Underperform Votes3431.48% SummaryPulse Biosciences beats AVITA Medical on 9 of the 15 factors compared between the two stocks. Ad Chaikin AnalyticsSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). Get AVITA Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RCEL vs. The Competition Export to ExcelMetricAVITA MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$267.70M$4.45B$5.40B$8.53BDividend YieldN/A42.37%5.15%4.14%P/E Ratio-5.2836.56112.5515.07Price / Sales4.9464.751,478.8293.55Price / CashN/A49.2739.8334.04Price / Book5.364.214.645.01Net Income-$35.38M$11.52M$119.13M$225.46M7 Day Performance1.68%1.05%0.78%0.37%1 Month Performance-6.45%0.94%5.65%3.57%1 Year Performance-2.55%39.40%36.90%29.42% AVITA Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RCELAVITA Medical1.1374 of 5 stars$10.30+2.0%$15.00+45.6%+5.6%$267.70M$54.14M-5.28130Upcoming EarningsNews CoveragePLSEPulse Biosciences1.2213 of 5 stars$17.36-0.4%N/A+232.4%$1.06B$700,000.000.00140Earnings ReportNews CoverageMDXGMiMedx Group4.0174 of 5 stars$7.05+2.9%$12.00+70.2%+7.4%$1.04B$321.48M12.82870Analyst UpgradeAnalyst RevisionNews CoverageAVNSAvanos Medical3.4953 of 5 stars$18.68+0.5%N/A-10.0%$858.35M$673.30M54.943,771News CoverageHigh Trading VolumeLQDALiquidia3.8717 of 5 stars$10.97+1.1%$24.67+124.9%+66.6%$842.39M$17.49M-6.9950Upcoming EarningsEYENational Vision3.6843 of 5 stars$10.47+0.7%$15.25+45.7%-29.4%$823.32M$2.16B-10.1713,998Upcoming EarningsShort Interest ↑EMBCEmbecta1.5027 of 5 stars$14.08-1.7%$12.00-14.8%-6.1%$812.42M$1.12B11.732,200Short Interest ↑Positive NewsCATXPerspective Therapeutics2.9996 of 5 stars$11.81+3.0%$20.63+74.6%N/A$796.33M$1.43M0.00116KIDSOrthoPediatrics4.0865 of 5 stars$26.85+1.2%$40.00+49.0%+11.1%$650.15M$175.07M-24.63200Upcoming EarningsIRMDIradimed4.8597 of 5 stars$49.27-6.9%$60.00+21.8%+17.6%$624.25M$69.48M33.75110Dividend AnnouncementNews CoverageHigh Trading VolumeAXGNAxoGen1.0629 of 5 stars$14.02+0.1%$15.00+7.0%+286.4%$614.50M$159.01M-36.89426Upcoming Earnings Related Companies and Tools Related Companies Pulse Biosciences Alternatives MiMedx Group Alternatives Avanos Medical Alternatives Liquidia Alternatives National Vision Alternatives Embecta Alternatives Perspective Therapeutics Alternatives OrthoPediatrics Alternatives Iradimed Alternatives AxoGen Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RCEL) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVITA Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCEL Stock Alerts